Dishman Pharmaceuticals to issue NCDs worth Rs 75 crore
Dishman Pharmaceuticals and Chemicals’ board has approved the proposal to issue non-convertible debentures (NCDs) up to an amount of Rs 75 crore, for augmenting medium to long-term resources of the company, including regular capital expenditure.
Dishman Pharmaceuticals is engaged in manufacturing of Bulk APIs, Intermediates, Specialties and Quats.
Popularity: 1% [?]
Category: Company Annoucements

